Netherlands· NL-a5029474f107
Gelofusine, oplossing voor intraveneuze infusie 40 g/l
A gelatine product containing chloride (cl-) + gelatine, gemodificeerd, gesuccinyleerd (molecuulgewicht onbekend) + natrium (na+) + natriumchloride, registered in Netherlands by B. Braun Melsungen AG (Melsungen). The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Gelatine is registered in 9 of 19 countries.
Countries holding a registration under ATC B05AA06 (gelatine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Gelatine · ATC B05AA06
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CHLORIDE (CL-) + GELATINE, GEMODIFICEERD, GESUCCINYLEERD (MOLECUULGEWICHT ONBEKEND) + NATRIUM (NA+) + NATRIUMCHLORIDE
- Manufacturer
- B. Braun Melsungen AG (Melsungen)
- Country
- Netherlands (NL)
- ATC code
- B05AA06
- ATC class
- Gelatine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id14368
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA06
Gelatine, as other registers publish it.
- NorwayGelaspanB. Braun Melsungen AG
- FinlandGelaspanB. Braun Melsungen AG
- PolandGelaspanB. Braun Melsungen AG
- DenmarkGelaspanB. Braun Melsungen
- CzechiaGELASPAN 4%B. Braun Melsungen AG, Melsungen
- CzechiaGELASPAN 4%B. Braun Melsungen AG, Melsungen
- IrelandGelaspan Solution for InfusionB. Braun Melsungen AG
- NetherlandsGelaspan, oplossing voor infusieB. Braun Melsungen AG (Melsungen)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56350f52-8935-41c4-a24e-9ca1adcd6ecb GET /v1/drugs/56350f52-8935-41c4-a24e-9ca1adcd6ecb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h14368_smpc.pdf",
"strength": null,
"atc_label": "Gelatin Agents",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg14368",
"excipients": [
"WATER, GEZUIVERD"
],
"substances": [
"CHLORIDE (CL-)",
"GELATINE, GEMODIFICEERD, GESUCCINYLEERD (MOLECUULGEWICHT ONBEKEND)",
"NATRIUM (NA+)",
"NATRIUMCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h14368.pdf",
"authorised_at": "1993/06/15",
"procedure_number": "NL/H/0394/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "14368",
"additional_monitoring": "N"
}See everything about gelatine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.